Also categorized in BoardNews:
Netflix: Icahn Says Poison Pill 'Poor Corporate Governance'
x hide permanently

Moderna Faces Shareholder Pressure Over Vaccine Costs

Moderna is fighting a shareholder proposal demanding the pharma group open up its Covid-19 vaccine technology to poorer countries and explain why its prices are so high given the amount of government assistance it has received...

Mentions: Shareholder Proposal technology Moderna